Sign in
4

Changes in Ownership

Twist Bioscience Corp Filed Acc 0001214659-26-014543

Chief Financial Officer sold 6,359 shares at $103.69 ($659,352)

  • Chief Financial Officer acquired 7,828 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Laponis Adam · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Sale : show line 1 in the form −6,359 $103.69 $659,352 118,501 D
2026-11-16 Grant or award : show line 2 in the form +7,828 126,329 D
Open-market sales · 6,359 sh · avg $103.69 · $659,352
Loading xslF345X06/marketforms-74342.xml…